HER2 copy number variation in non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Tagliamento, M. [1 ]
Auclin, E. [2 ]
Valent, A. [3 ]
Ferrara, R. [4 ]
Cotteret, S. [3 ]
Rouleau, E. [3 ]
Caramella, C. [5 ]
Melia, M. Riudavets [1 ]
Gazzah, A. [6 ]
Adam, J. [3 ]
Jovelet, C. [3 ]
Bayle, A. [6 ]
Lacroix, L. [3 ]
Auger, N. [3 ]
Barlesi, F. [7 ]
Planchard, D. [1 ]
Besse, B. [8 ]
Mezquita, L. [9 ]
机构：
[1] Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Hop Europeen Georges Pompidou, AP HP, Oncol Dept, Paris, France
[3] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France
[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[5] Hop Marie Lannelongue, Dept Radiol, Le Plessis Robinson, France
[6] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[7] Gustave Roussy, Dept Canc Med, Villejuif, France
[8] Gustave Roussy, Canc Med Dept, Villejuif, France
[9] Hosp Clin Barcelona, Div Med Oncol, Lab Translat Genom & Targeted Therapies Solid Tum, IDIBAPS, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1090P
引用
收藏
页码：S1050 / S1050
页数：1
相关论文
共 50 条
  • [1] EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
    Cappuzzo, Federico
    Ligorio, Claudio
    Toschi, Luca
    Rossi, Elisa
    Trisolini, Rocco
    Paioli, Daniela
    Magrini, Elisabetta
    Finocchiaro, Giovanna
    Bartolini, Stefania
    Cancellieri, Alessandra
    Hirsch, Fred R.
    Crino, Lucio
    Varella-Garcia, Marileila
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : 423 - 429
  • [2] P95HER2 TRUNCATED FORM AND HER2 GENE COPY NUMBER IN NON-SMALL-CELL LUNG CANCER (NSCLC)
    Cappuzzo, Federico
    Cho, Yong Gon
    Ali, Greta
    Incarbone, Matteo
    Destro, Annarita
    Terracciano, Luigi
    Fontanini, Gabriella
    Marchetti, Antonio
    Roncalli, Massimo
    Varella-Garcia, Marileila
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S505 - S506
  • [3] HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches
    Christina Garrido-Castro, Ana
    Felip, Enriqueta
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 122 - 127
  • [4] Correlation between encoded protein overexpression and copy number of the HER2 gene with survival in non-small cell lung cancer
    Nakamura, H
    Saji, H
    Ogata, A
    Hosaka, M
    Hagiwara, M
    Kawasaki, N
    Kato, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 61 - 66
  • [5] Investigation of HER2 overexpression in non-small cell lung cancer
    Ugocsai, K
    Mándoky, L
    Tiszlavicz, L
    Molnár, J
    [J]. ANTICANCER RESEARCH, 2005, 25 (04) : 3061 - 3066
  • [6] Targeting HER2 in the treatment of non-small cell lung cancer
    Mar, Nataliya
    Vredenburgh, James J.
    Wasser, Jeffrey S.
    [J]. LUNG CANCER, 2015, 87 (03) : 220 - 225
  • [7] HER1, HER2, HER3 and HER4 gene copy number and protein expression in non-small cell lung cancer
    Jeon, Y.
    Kim, Y.
    Sung, S.
    Seo, J.
    Chung, D.
    [J]. HISTOPATHOLOGY, 2008, 53 : 350 - 350
  • [8] HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
    Uy, Natalie F.
    Merkhofer, Cristina M.
    Baik, Christina S.
    [J]. CANCERS, 2022, 14 (17)
  • [9] HER2 mutations in Chinese patients with non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    Shi, Zhiyong
    Zhao, Jun
    Zhang, Yiping
    [J]. ONCOTARGET, 2016, 7 (47) : 78152 - 78158
  • [10] Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib
    Liu, Shengwu
    Li, Shuai
    Hai, Josephine
    Wang, Xiaoen
    Chen, Ting
    Quinn, Max M.
    Gao, Peng
    Zhang, Yanxi
    Ji, Hongbin
    Cross, Darren A. E.
    Wong, Kwok-Kin
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2594 - 2604
12345